Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: Retina. 2013 May;33(5):946–952. doi: 10.1097/IAE.0b013e3182753b12

Table 2.

Thyroid Radioactivity Levels (Bq/mL)

Day Bev. 1-Control Bev. 2-Control Bev. 3-Control Ran. 1-Control Ran. 2-Control Ran. 3-Control
2 429.4 490.6 351.3 475.0 410.0 464.9
5 311.4 388.5 272.8 321.0 416.0 367.6
7 224.0 323.4 217.3 207.1 297.1 294.4
14 77.2 113.8 71.1 43.5 71.8 59.1
21 33.6
Day Bev. 1-PPV Bev. 2-PPV Bev. 3-PPV Ran. 1-PPV Ran. 2-PPV Ran. 3-PPV
2 2,267.8 1,176.5 2,490.6 2,225.4 2,406.3 1,144.7
5 2,268.2 1,618.5 2,799.8 1,424.6 1,278.0 656.7
7 1,463.8 940.2 2,084.6 852.2 792.6 379.4
14 430.4 235.0 605.3 152.4 162.2 52.0
21 89.2 63.0 91.3 27.9 35.2 8.7
28 21.3 17.3 32.4 10.7 6.1
35 10.9
Day Bev. 1-PPL Bev. 2-PPL Bev. 3-PPL Ran. 1-PPL Ran. 2-PPL Ran. 3-PPL
2 1,879.2 3,095.4 3,306.2 4,453.2 10,001.2 4,248.3
5 1,242.4 2,183.1 2,599.3 2,355.4 4,965.8 1,804.7
7 890.7 1,400.4 2,039.7 1,444.5 2,879.3 1,077.2
14 332.7 359.0 551.7 251.6 548.7 219.5
21 70.1 79.9 145.8 82.0 108.1 48.7

Bev., bevacizumab; PPL, pars plana lensectomy; PPV, pars plana vitrectomy; Ran., ranibizumab.